cysteine has been researched along with 4-(n-maleimido)benzyltrimethylammonium in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cohen, JB; Sullivan, DA | 1 |
Boo, I; Drummer, HE; Fraser, J; Poumbourios, P | 1 |
2 other study(ies) available for cysteine and 4-(n-maleimido)benzyltrimethylammonium
Article | Year |
---|---|
Mapping the agonist binding site of the nicotinic acetylcholine receptor. Orientation requirements for activation by covalent agonist.
Topics: Acetylcholine; Affinity Labels; Alkylation; Animals; Binding Sites; Cysteine; Dose-Response Relationship, Drug; Ethyl Methanesulfonate; Indicators and Reagents; Kinetics; Mesylates; Models, Chemical; Mutagenesis; Nicotinic Agonists; Patch-Clamp Techniques; Protein Structure, Quaternary; Quaternary Ammonium Compounds; Receptors, Nicotinic; Time Factors; Transcription, Genetic; Xenopus | 2000 |
Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 contain reduced cysteine residues essential for virus entry.
Topics: Alkylating Agents; Alkylation; Cysteine; HEK293 Cells; Hepacivirus; Humans; Oxidation-Reduction; Protein Multimerization; Quaternary Ammonium Compounds; Recombinant Proteins; Tetraspanin 28; Viral Envelope Proteins; Virus Internalization | 2011 |